{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:23:35Z","timestamp":1774398215530,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12288-017-0776-1","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T15:57:14Z","timestamp":1484150234000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cost-Effectiveness of Autologous Stem Cell Treatment as Compared to Conventional Chemotherapy for Treatment of Multiple Myeloma in India"],"prefix":"10.1007","volume":"33","author":[{"given":"Shankar","family":"Prinja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Jyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Bahuguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"key":"776_CR1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","volume":"374","author":"M Raab","year":"2009","unstructured":"Raab M, Podar K, Breitkreutz I, Richardson P, Anderson K (2009) Multiple myeloma. Lancet 374:324\u2013339","journal-title":"Lancet"},{"key":"776_CR2","first-page":"80","volume":"19","author":"L Kumar","year":"2006","unstructured":"Kumar L, Vikram P, Kochupillai V (2006) Recent advances in the management of multiple myeloma. Natl Med J India 19:80","journal-title":"Natl Med J India"},{"key":"776_CR3","unstructured":"Ghalaut P, Chaudhuri S, Singh R (2013) Recent advances in diagnosis and management of multiple myeloma: an update. The Association of Physicians of India, Medicine Update, pp 360\u2013365"},{"key":"776_CR4","doi-asserted-by":"crossref","unstructured":"Agarwal M (2016) Multiple myeloma: treatment is getting individualized. Indian Soc Haematol Transfus Med 32(1)","DOI":"10.1007\/s12288-015-0575-5"},{"issue":"2","key":"776_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau J, Stoppa A, Sotto E, Fuzibet J, Rossi J et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335(2):91\u201397","journal-title":"N Engl J Med"},{"issue":"19","key":"776_CR6","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"J Child","year":"2003","unstructured":"Child J, Morgan G, Davies F, Owen R, Bell S, Hawkins K et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348(19):1875\u20131883","journal-title":"N Engl J Med"},{"key":"776_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","volume":"13","author":"J Koreth","year":"2007","unstructured":"Koreth J, Cutler C, Djulbegovic B, Behl R, Schlossman R, Munshi N et al (2007) High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transplant 13:183\u2013196","journal-title":"Biol Blood Marrow Transplant"},{"key":"776_CR8","volume-title":"Key indicators of social consumption in India Health NSS 71st Round (January\u2013June 2014)","author":"NSSO","year":"2015","unstructured":"NSSO (2015) Key indicators of social consumption in India Health NSS 71st Round (January\u2013June 2014). National Sample Survey Organization, Ministry of Statistics and Programme Implementation, Government of India, New Delhi"},{"key":"776_CR9","doi-asserted-by":"crossref","DOI":"10.1596\/13649","volume-title":"The economic implications of non-communicable disease for India","author":"A Mahal","year":"2010","unstructured":"Mahal A, Karan A, Engelau M (2010) The economic implications of non-communicable disease for India. World Bank, Washington"},{"key":"776_CR10","unstructured":"Twelfth Five Year Plan (2012\u20132017) Social sectors, volume III. SAGE Publications India Pvt Ltd. http:\/\/planningcommission.gov.in\/plans\/planrel\/12thplan\/pdf\/12fyp_vol3.pdf"},{"key":"776_CR11","volume-title":"A critical assessment of the existing health insurance models in India","author":"PHFI","year":"2011","unstructured":"PHFI (2011) A critical assessment of the existing health insurance models in India. Public Health Foundation of India, New Delhi"},{"issue":"6","key":"776_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40258-015-0201-6","volume":"13","author":"S Prinja","year":"2015","unstructured":"Prinja S, Chauhan AS, Angell B, Gupta I, Jan S (2015) A systematic review of the state of economic evaluation for health care in India. Appl Health Econ Health Policy 13(6):595\u2013613. doi: 10.1007\/s40258-015-0201-6","journal-title":"Appl Health Econ Health Policy"},{"key":"776_CR13","unstructured":"ISPOR (2016) Pharmacoeconomics & outcomes research guidelines for India PEOR guidelines [Internet]. https:\/\/www.ispor.org\/consortiums\/asia\/PEGuidelines_India_March2016.pdf"},{"issue":"15","key":"776_CR14","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"P Greipp","year":"2005","unstructured":"Greipp P, Miguel J, Durie B, Crowley J, Barlogie B, Blad\u00e9 J et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412\u20133420","journal-title":"J Clin Oncol"},{"key":"776_CR15","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1016\/j.vaccine.2013.06.060","volume":"31","author":"M Fesenfeld","year":"2013","unstructured":"Fesenfeld M, Hutubessy R, Jit M (2013) Cost-effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review. Vaccine 31:3786\u20133804","journal-title":"Vaccine"},{"key":"776_CR16","doi-asserted-by":"crossref","unstructured":"Picot J, Cooper K, Bryant J, Clegg AJ (2011) The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation. Health Technol Assess 15(41):23\u201347","DOI":"10.3310\/hta15410"},{"issue":"1","key":"776_CR17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/S0266462313000615","volume":"30","author":"K Cooper","year":"2014","unstructured":"Cooper K, Picot J, Bryant J, Clegg A (2014) Comparative cost-effectiveness models for the treatment of multiple myeloma. Int J Technol Assess Health Care 30(1):90\u201397","journal-title":"Int J Technol Assess Health Care"},{"issue":"6","key":"776_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bmt.2008.343","volume":"43","author":"L Kumar","year":"2009","unstructured":"Kumar L, Ghosh J, Ganessan P, Gupta A, Hariprasad R, Kochupillai V (2009) High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country. Bone Marrow Transplant 43(6):481\u2013489","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"776_CR19","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2007-03-081018","volume":"111","author":"H Ludwig","year":"2008","unstructured":"Ludwig H, Durie B, Bolejack V, Turesson I, Kyle R, Blade J et al (2008) Myeloma in patients younger than age 50\u00a0years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood 111(8):4039\u20134047","journal-title":"Blood"},{"issue":"2","key":"776_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5455\/2319-2003.ijbcp20130302","volume":"2","author":"M Gupta","year":"2013","unstructured":"Gupta M, Pal R, Tikoo D (2013) Multiple myeloma: the disease and its treatment. Int J Basic Clin Pharmacol 2(2):103-21","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"8","key":"776_CR21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ejca.2004.01.019","volume":"40","author":"M Agthoven Van","year":"2004","unstructured":"Van Agthoven M, Segeren C, Buijt I, Uyl-de Groot C, van der Holt B, Lokhorst H et al (2004) A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II\/III multiple myeloma. Eur J Cancer 40(8):1159\u20131169","journal-title":"Eur J Cancer"},{"issue":"1","key":"776_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7525-12-35","volume":"12","author":"I Proskorovsky","year":"2014","unstructured":"Proskorovsky I, Lewis P, Williams C, Jordan K, Kyriakou C, Ishak J et al. (2014) Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Health and Quality of Life Outcomes 12(1):35","journal-title":"Health and Quality of Life Outcomes"},{"issue":"3","key":"776_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/COH.0b013e32833860e9","volume":"5","author":"EJ Beck","year":"2010","unstructured":"Beck EJ, Harling G, Gerbase S, DeLay P (2010) The cost of treatment and care for people living with HIV infection: implications of published studies, 1999\u20132008. Curr Opin HIV AIDS 5(3):215\u2013224","journal-title":"Curr Opin HIV AIDS"},{"key":"776_CR24","doi-asserted-by":"crossref","first-page":"23573","DOI":"10.3402\/gha.v7.23573","volume":"7","author":"ME Hendriks","year":"2014","unstructured":"Hendriks ME, Kundu P, Boers AC, Bolarinwa OA, Te Pas MJ, Akande TM et al (2014) Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology. Glob Health Action 7:23573","journal-title":"Glob Health Action"},{"key":"776_CR25","volume-title":"Methods for the costing component of the multi-country evaluation of IMNCI","author":"T Adam","year":"2004","unstructured":"Adam T, Bishai D, Khan MM, Evans DB (2004) Methods for the costing component of the multi-country evaluation of IMNCI. Department of Child and Adolescent Health and Development, World Health Organization, Geneva"},{"issue":"8","key":"776_CR26","doi-asserted-by":"publisher","first-page":"e0160986","DOI":"10.1371\/journal.pone.0160986","volume":"11","author":"S Prinja","year":"2016","unstructured":"Prinja S, Gupta A, Verma R, Bahuguna P, Kumar D, Kaur M, Kumar R (2016) Cost of delivering health care services in public sector primary and community health centres in North India. PLoS ONE 11(8):e0160986. doi: 10.1371\/journal.pone.0160986","journal-title":"PLoS ONE"},{"key":"776_CR27","doi-asserted-by":"crossref","unstructured":"Prinja S, Balasubramanian D, Jeet G, Verma R, Kumar D, Bahuguna P, Kaur M, Kumar R (2016) Cost of delivering secondary level health care services through public sector district hospitals in India. Indian J Med Res (forthcoming)","DOI":"10.4103\/ijmr.IJMR_902_15"},{"issue":"3","key":"776_CR28","doi-asserted-by":"publisher","first-page":"e91781","DOI":"10.1371\/journal.pone.0091781","volume":"9","author":"S Prinja","year":"2014","unstructured":"Prinja S, Jeet G, Verma R, Kumar D, Bahuguna P, Kaur M, Kumar R (2014) Economic analysis of delivering primary health care services through community health workers in 3 North Indian States. PLoS ONE 9(3):e91781. doi: 10.1371\/journal.pone.0091781","journal-title":"PLoS ONE"},{"issue":"6","key":"776_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/tropej\/fmt057","volume":"59","author":"S Prinja","year":"2013","unstructured":"Prinja S, Mazumder S, Taneja S, Bahuguna P, Bhandari P, Mohan P, Hombergh H, Kumar R (2013) Cost of delivering child health care through community level health workers: how much does extra does IMNCI cost? J Trop Pediatr 59(6):489\u2013495. doi: 10.1093\/tropej\/fmt057","journal-title":"J Trop Pediatr"},{"key":"776_CR30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s13312-013-0234-6","volume":"50","author":"S Prinja","year":"2013","unstructured":"Prinja S, Manchanda N, Mohan P, Gupta G, Sethy G, Sen A, Hombergh HVD, Kumar R (2013) Cost of neonatal intensive care delivered through district level public hospitals in India. Indian Pediatr 50:765\u2013772","journal-title":"Indian Pediatr"},{"issue":"11","key":"776_CR31","doi-asserted-by":"publisher","first-page":"e0166775","DOI":"10.1371\/journal.pone.0166775","volume":"11","author":"I Gupta","year":"2016","unstructured":"Gupta I, Chowdhury S, Prinja S, Trivedi M (2016) Out-of-pocket spending on out-patient care in india: assessment and options based on results from a district level survey. PLoS ONE 11(11):e0166775. doi: 10.1371\/journal.pone.0166775","journal-title":"PLoS ONE"},{"issue":"9","key":"776_CR32","doi-asserted-by":"crossref","first-page":"e0137315","DOI":"10.1371\/journal.pone.0137315","volume":"10","author":"S Prinja","year":"2015","unstructured":"Prinja S, Bahuguna P, Gupta R, Sharma A, Rana SK, Kumar R (2015) Coverage and financial risk protection for institutional delivery: how universal Is provision of maternal health care in India? PLoS ONE 10(9):e0137315","journal-title":"PLoS ONE"},{"key":"776_CR33","doi-asserted-by":"crossref","unstructured":"Prinja S, Gupta R, Bahuguna P, Sharma A, Aggarwal AK, Phogat A, Kumar R (2016) A composite indicator to measure universal health care coverage in india: way forward for post-2015 health system performance monitoring framework. Health Policy Plann. pii:czw097 (Epub ahead of print)","DOI":"10.1093\/heapol\/czw097"},{"key":"776_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/ijerph13070673","volume":"13","author":"S Prinja","year":"2016","unstructured":"Prinja S, Jagnoor J, Chauhan AS, Aggarwal S, Nguyen H, Ivers R (2016) Economic burden of hospitalization due to injuries in North India: A cohort study. Int J Environ Res Public Health 13:673. doi: 10.3390\/ijerph13070673","journal-title":"Int J Environ Res Public Health"},{"key":"776_CR35","unstructured":"(2015) The economic times: forex rates.\u00a0 http:\/\/economictimes.indiatimes.com\/markets\/forex"},{"key":"776_CR36","unstructured":"GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide 2012: international agency for research on cancer. http:\/\/globocan.iarc.fr\/Pages\/factsheetspopulation.aspx"},{"key":"776_CR37","first-page":"23","volume":"57","author":"J Prakash","year":"2009","unstructured":"Prakash J, Niwas SS, Parekh A, Vohra R, Wani IA, Sharma N, Usha (2009) Multiple myeloma\u2013presenting as acute kidney injury. J Assoc Physicians India 57:23\u20136","journal-title":"J Assoc Physicians India"},{"key":"776_CR38","unstructured":"Maheshwari A (2014) Cost effectiveness of treatment of guillain barre syndrome with iv immunoglobulins versus plasmapharesis [MD thesis]. PGIMER, Chandigarh"},{"key":"776_CR39","unstructured":"Sangwan A (2015) Cost of trauma care in secondary and tertiary care public sector hospitals in north india [MPH thesis]. PGIMER, Chandigarh"},{"issue":"1","key":"776_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10428190309178811","volume":"44","author":"CT Kouroukis","year":"2003","unstructured":"Kouroukis CT, O\u2019brien BJ, Benger A, Marcellus D, Foley R, Garner J, Ingram C, Haines P, Henderson-O\u2019Connor N, Meyer R (2003) Cost-effectiveness of a transplantation strategy compared to melphalan and prednisone in younger patients with multiple myeloma. Leuk Lymphoma 44(1):29\u201337","journal-title":"Leuk Lymphoma"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-017-0776-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-017-0776-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-017-0776-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T09:33:28Z","timestamp":1749893608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-017-0776-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s12288-017-0776-1","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}